UBS lowered the firm’s price target on Arthur J. Gallagher (AJG) to $283 from $285 and keeps a Neutral rating on the shares. Insurance brokers are well positioned for 2026, with organic revenue growth averaging 4.4% and EBITDA margins improving year over year despite property rate pressures, the analyst tells investors in a research note. With growth expectations reset and valuations reflecting a softer market, there is upside to consensus EPS and potential for multiple expansion, the firm says.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AJG:
- Arthur J. Gallagher acquires Reck & Co, terms undisclosed
- Arthur J. Gallagher Extends Growth Streak With Strong Call
- Arthur J. Gallagher & Co.: Reaffirmed Growth Outlook and Margin Expansion Support Buy Rating
- Arthur J. Gallagher price target lowered to $271 from $280 at Truist
- Arthur J. Gallagher price target lowered to $249 from $272 at Piper Sandler